Antonella Riccardi
Overview
Explore the profile of Antonella Riccardi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
217
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liem S, Boonstra M, le Cessie S, Riccardi A, Airo P, Distler O, et al.
Lancet Rheumatol
. 2024 Jan;
4(10):e699-e709.
PMID: 38265968
Background: We aimed to evaluate sex-specific risk of anti-topoisomerase I antibodies (ATA) on mortality, diffuse cutaneous systemic sclerosis, interstitial lung disease, and pulmonary hypertension in two cohorts of people with...
2.
Riccardi A, Martinroche G, Contin-Bordes C, Avouac J, Gobeaux C, Cauvet A, et al.
Semin Arthritis Rheum
. 2022 Jan;
52:151947.
PMID: 35000789
Objective: We aimed to evaluate in two large SSc French cohorts the prevalence and associated factors with the autoantibodies linked to erosive arthritis. Methods: 448 SSc patients were recruited from...
3.
Riccardi A, Marcoccia A, Modesti M, Bondanini F, Irace R, Messiniti V, et al.
Autoimmun Rev
. 2021 Jan;
20(3):102751.
PMID: 33476821
No abstract available.
4.
Hoffmann-Vold A, Allanore Y, Alves M, Brunborg C, Airo P, Ananieva L, et al.
Ann Rheum Dis
. 2020 Sep;
80(2):219-227.
PMID: 32988845
Objectives: To identify overall disease course, progression patterns and risk factors predictive for progressive interstitial lung disease (ILD) in patients with systemic sclerosis-associated ILD (SSc-ILD), using data from the European...
5.
Fasano S, Iacono D, Riccardi A, Ciccia F, Valentini G
Rheumatology (Oxford)
. 2020 Aug;
59(12):3593-3602.
PMID: 32830272
Aspirin is the most commonly used medication worldwide. Beside its well-known anti-inflammatory effects, a role has emerged in the prevention of cardiovascular events. However, a significant benefit has been demonstrated...
6.
Riccardi A, Marcoccia A, Valentini G
J Rheumatol
. 2020 Jul;
47(11):1724.
PMID: 32669449
No abstract available.
7.
Hughes M, Heal C, Siegert E, Hachulla E, Airo P, Riccardi A, et al.
Ann Rheum Dis
. 2020 Mar;
79(8):1123-1125.
PMID: 32213494
No abstract available.
8.
Fasano S, Pierro L, Borgia A, Coscia M, Formica R, Bucci L, et al.
Rheumatology (Oxford)
. 2020 Mar;
59(11):3193-3200.
PMID: 32211780
Objective: Recent evidence suggests that some urinary biomarkers, namely Vascular Cell Adhesion Molecule-1 (VCAM-1), Intercellular Adhesion Molecule-1 (ICAM-1), Monocyte Chemoattractant Protein 1 (MCP-1), Neutrophil Gelatinase Associated Lipocalcin and Lipocalin-type Prostaglandin...
9.
Fasano S, Riccardi A, Messiniti V, Caramaschi P, Rosato E, Maurer B, et al.
Ann Rheum Dis
. 2019 Aug;
78(12):1681-1685.
PMID: 31422354
Background: The European Scleroderma Trials and Research Group (EUSTAR) recently developed a preliminarily revised activity index (AI) that performed better than the European Scleroderma Study Group Activity Index (EScSG-AI) in...
10.
Valentini G, Huscher D, Riccardi A, Fasano S, Irace R, Messiniti V, et al.
Ann Rheum Dis
. 2019 Aug;
78(11):1576-1582.
PMID: 31391176
Objectives: To investigate the influence of vasodilator drugs on the occurrence of features depending on myocardial ischaemia/fibrosis (ventricular arrhythmias, Q waves, cardiac blocks, pacemaker implantation, left ventricular ejection fraction (LVEF)...